Dr. Stuti Pandey

About

I have completed Ph.D. in medicinal chemistry from Delhi University, New Delhi, India. I have done extensive training and experience in the design and synthesis library of novel Bis-benzimidazole and Bis-Benzithiazole molecule inhibitor and minor groove binder with DNAs. I have studied their different aspects in terms of DNA interaction by performing different biophysical techniques which developed a new approach to study those novel molecules towards cancer. I have an expertise in Molecular modelling to correlate all experimental data. I have experience in cell culturing and analysing their biological activities against cancer.

Employment

Employment history is unavailable.

Education

• University of Delhi Ph.D.
  2014 - 2021

Projects & Funding

Projects & funding information is unavailable.

Publications (4)

• Synthesis and Biological Evaluation of Novel 1H-Benzo[d]imidazole Derivatives as Potential Anticancer Agents Targeting Human Topoisomerase I.
  ACS omega 2022 DOI: 10.1021/acsomega.1c05743
  +Save
• PPEF: A bisbenzimdazole potent antimicrobial agent interacts at acidic triad of catalytic domain of E. coli topoisomerase IA.
  Biochimica et biophysica acta. General subjects 2019 DOI: 10.1016/j.bbagen.2019.05.015
  +Save
• Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.
  Scientific reports 2017 DOI: 10.1038/srep44419
  +Save
• Topoisomerases: Resistance versus Sensitivity, How Far We Can Go?
  Medicinal Research Reviews 2017 DOI: 10.1002/med.21417
  +Save